• Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz exercised stock options for 31,249 common shares at $21.77 on July 9.
• Savitz sold 31,249 common shares the same day in three blocks at weighted average prices of $100.22, $101.24, $101.97.
• He ended the day with 0 common shares directly owned.
• He reported 68,751 stock options remaining after the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001992324-26-000008), on July 13, 2026, and is solely responsible for the information contained therein.